Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
78.89
-0.38 (-0.48%)
At close: Jun 26, 2026, 4:00 PM EDT
80.45
+1.55 (1.97%)
After-hours: Jun 26, 2026, 7:47 PM EDT
Arrowhead Pharmaceuticals Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Arrowhead Pharmaceuticals stock have an average target of 90, with a low estimate of 46 and a high estimate of 110. The average target predicts an increase of 14.08% from the current stock price of 78.89.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Arrowhead Pharmaceuticals stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 3 | 4 | 4 |
| Hold | 4 | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 12 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $100 | Buy | Reiterates | $100 | +26.76% | Jun 26, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $100 | Buy | Maintains | $100 | +26.76% | May 27, 2026 |
| Bernstein | Bernstein | Hold Reiterates $35 → $46 | Hold | Reiterates | $35 → $46 | -41.69% | May 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $110 | Buy | Reiterates | $110 | +39.43% | May 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $87 | Buy | Maintains | $87 | +10.28% | May 8, 2026 |
Financial Forecast
Revenue This Year
444.25M
from 829.45M
Decreased by -46.44%
Revenue Next Year
337.40M
from 444.25M
Decreased by -24.05%
EPS This Year
-3.00
from -0.01
EPS Next Year
-4.34
from -3.00
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 618.0M | 567.0M | |
| Avg | 444.3M | 337.4M | |
| Low | 340.0M | 114.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -25.5% | 27.6% | |
| Avg | -46.4% | -24.1% | |
| Low | -59.0% | -74.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.73 | -1.81 | |
| Avg | -3.00 | -4.34 | |
| Low | -3.82 | -6.70 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.